HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$0.62
Day range
$0.61 - $0.66
Year range
$0.61 - $2.53
Market cap
56.38M USD
Avg Volume
527.19K
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 4.80M | — |
Operating expense | 12.97M | 54.45% |
Net income | -13.88M | -142.26% |
Net profit margin | -289.25 | — |
Earnings per share | -0.09 | — |
EBITDA | -11.72M | -42.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.99M | -15.83% |
Total assets | 63.92M | -16.31% |
Total liabilities | 50.70M | 98.50% |
Total equity | 13.22M | — |
Shares outstanding | 1.09B | — |
Price to book | 62.14 | — |
Return on assets | -50.79% | — |
Return on capital | -115.71% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -13.88M | -142.26% |
Cash from operations | 4.99M | 187.82% |
Cash from investing | -20.40M | -628.09% |
Cash from financing | 11.74M | 1,914.53% |
Net change in cash | -3.47M | -37.89% |
Free cash flow | 8.91M | 350.95% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
79
